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It is demonstrated that in chicken embryonic and mature erythrocyte nuclei the distribution of a versatile transcription factor CTCF differs
drastically from its distribution in nuclei of proliferating erythroid and non-erythroid cells. In the latter case CTCF was distributed throughout the
whole nucleus volume, being concentrated in many small compartments (punctuate nuclear staining). In contrast, in embryonic and mature
erythrocytes CTCF was concentrated in a limited number of large compartments. These large CTCF-containing compartments were not observed
in other cells. Occasionally, but not in all cells, some of these compartments were localized close to nucleoli but did not colocalize with them. In
mature erythrocytes a clear exclusion of CTCF-containing compartments from the chromatin domain was observed. This exclusion correlated with
a tight association of CTCF with the nuclear matrix. Concentration in relatively large compartments and exclusion from the chromatin domain in
nuclei of mature erythrocytes were also observed for RNA polymerase II and several transcription factors. The data are discussed in the context of
a hypothesis postulating that relocalization of different components of the transcriptional machinery from the chromatin domain into the
interchromatin compartment is an important step of the terminal inactivation of chicken erythrocyte nuclei.
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It becomes increasingly evident that the specific spatial
organization of the genome in eukaryotic cell nuclei plays an
important role in the regulation of gene expression [1–3].
According to the current model of the eukaryotic cell nucleus
organization, individual chromosomes occupy relatively com-
pact non-overlapping spaces named chromosomal territories.
The chromosomal territories are separated by the so-called
interchromatin domain (ICD) [4,5]. In transcriptionally-activeAbbreviations: ICD, interchromatin domain; RBC, red blood cells; eRBC,
embryonic red blood cells; CEF, chicken embryonic fibroblasts; DAPI, 4,6-
diamino-2-phenylindole
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components of the transcriptional machinery both within
chromosomal territories and in ICD. Indeed, the common
transcription factors are usually distributed over the whole
nuclear volume, in some cases being concentrated in numerous
small compartments (punctuate nuclear staining) [6–11]. Dy-
namic changes in the localization of nuclear transcription factors
may be of functional significance [12].
CTCF is a multifunctional DNA-binding protein originally
described as a transcription factor regulating c-myc gene
expression [13,14]. Later CTCF was found to play an essential
role in the functioning of enhancer-blocking elements [15,16].
Recent analysis of the CTCF nuclear distribution showed it to
be drastically different in proliferating and non-proliferating
cells. In particular it was demonstrated that the proliferation
arrest (for example in the case of induced terminal diffe-
rentiation of cultured human erythroid K562 cells) correlated
with targeting of CTCF to nucleoli [17]. As it is known that
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it was proposed that CTCF induced a proliferation arrest by
affecting the normal function of nucleoli [17].
To gain a better insight into possible functions of CTCF in
terminal differentiation of erythroid cells, we studied the nuclear
distribution of CTCF in cultured chicken erythroblasts (AEV-
transformed HD3 cells), in normal chicken embryonic erythro-
cytes (9-day red blood cells, eRBC) and in terminally dif-
ferentiated chicken erythrocytes with completely inactive nuclei
(RBC). We found that in the course of differentiation of erythroid
cells CTCF was progressively excluded from chromatin into
DNA-free areas (presumably ICD) and in the peripheral layer. In
these areas it was concentrated in a few relatively large
compartments. In eRBC some of these compartments were
occasionally localized in close proximity to nucleoli. A
considerable portion of CTCF-containing compartments was
detected in the peripheral nuclear layer. Concentration in large
compartments excluded from chromatin in mature chicken
erythrocytes was not an exceptional feature of the CTCF
distribution. A similar exclusion from chromatin was observed
for RNA polymerase II and several transcription factors. We
suppose that such exclusion constitutes one of the steps of nucleus
inactivation in mature avian erythrocytes.2. Materials and methods
2.1. Antibodies
A rabbit polyclonal antibody against CTCF and the mouse monoclonal
antibodies against fibrillarin and SC35 were purchased from Abcam (Cam-
bridge, UK). A mouse monoclonal antibody anti-RNA polymerase II was from
Chemicon/Millipore (Billerica, MA); the mouse monoclonal antibodies anti-
pCREB and anti-coilin were from Santa Cruz Biotechnology (Santa Cruz, CA).
The monoclonal mouse antibody against the transcription factor Kaiso (clones
12H and GF) was a generous gift of Dr. E. Prokhortchouk (Bioengineering
Centre of the Russian Academy of Sciences, Moscow, Russia). The monoclonal
antibodies against proteasomal core proteins p23 and p27 were a generous gift of
Prof. K. Scherrer (Institute J. Monod, Paris, France). The polyclonal rat antibody
against YB-1 protein was a generous gift of Prof. L. Ovchinnikov (Institute of
Protein, Pushino, Russia). The secondary antibodies conjugated with Alexa
Fluor 488, Alexa Fluor 594, FITC or Rhodamine Red were from Molecular
Probes/Invitrogene (Paisley, UK).
2.2. Cell culture
The avian erythroblastosis virus-transformed chicken erythroblast cell line
HD3 was maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco)
supplemented with 8% fetal bovine serum and 2% chicken serum. Primary
chicken embryonic fibroblasts (CEF) were prepared from 9-day-old chicken
embryos [19] and grown in DMEM supplemented with 8% fetal bovine serum
and 2% chicken serum. Nine-day chicken embryonic red blood cells (eRBC)
were prepared as described previously [20] and kept in cold PBS (7 mM
Na2HPO4, 1.5 mM KH2PO4, (pH 7.4), 137 mM NaCl, 2.7 mM KCl). Mature
chicken erythrocytes (or red blood cells, RBC) were obtained from White
Leghorn chickens and kept in cold 125 mM EDTA solution.
2.3. Immunofluorescence
For immunostaining an aliquot of the suspension of HD3 cells, eRBC or
RBC was centrifuged onto silane-coated microscope slides (Sigma) at 800 r.p.m.
for 5 min in a cytocentrifuge Cytospin 4 (Thermo Electron Corp.). CEF were
grown on microscope slides. Before immunostaining, all samples were fixed andpermeabilized in a CSK buffer (10 mM PIPES (pH 7.0), 100 mM NaCl, 1.5 mM
MgCl2, 300 mM sucrose and 1.2 mM phenylmethylsulphonilfluoride (PMSF))
supplemented with 1% paraformaldehyde (PFA) and 2.5% Triton X-100 for
20 min at room temperature. The fixed cells were washed three times (5 min
each time) in phosphate-buffered saline (PBS, 7 mM Na2HPO4, 1.5 mM
KH2PO4, (pH 7.4), 137 NaCl, 2.7 mM KCl). After washing, the cells were
preincubated for 1 h with 1% BSA (bovine serum albumin) in PBS and then
incubated with antibodies in PBS supplemented with 0.2% BSA for 45 min at
room temperature in a humid chamber. In control experiments, the cells were
incubated either without antibodies or with rabbit (or mouse) gamma globulins
(Jackson ImmunoResearch) in a buffer containing 0.2% BSA. After incubation,
the cells were washed three times (5 min each time) with PBS supplemented
with 0.2% BSA and 0.05% Tween 20. Then, primary antibodies bound to
antigens were revealed using Alexa Fluor 488, or Alexa Fluor 594, or FITC, or
Rhodamine Red-conjugated secondary antibodies. DNA was stained with a
fluorescent dye 4,6-diamino-2-phenylindole (DAPI) for 15 min at room
temperature. The results of immunostaining were analysed using a Leica
DRMB fluorescence microscope equipped with a charge-coupled device camera
or a Leica TCS laser scanning confocal microscope.
2.4. Preparation of nuclear extracts
For DNAse I/NaCl extraction 8×107 eRBCs or RBC were collected by
centrifugation and washed twice with PBS. Then, the cells were incubated for
30 min on ice in permeabilization buffer (10 mM PIPES, (pH 7.8), 0.5% Triton
X-100, 100 mM NaCl, 0.3 M sucrose, 0.2 mM PMSF and 3 mMMgCl2). After
incubation, the cells were washed three times with TM buffer (50 mM Tris–HCl
pH 7.5, 3 mM MgCl2) and then treated with RNase-free DNase I (100 μg/ml)
(Sigma) for 30 min at 37 °C in 200 μl of TM buffer. An equal volume of TM
buffer supplemented with 0.6 M or 4 M NaCl was added (final concentration of
NaCl was 0.3 M and 2 M, respectively). After 20-min incubation on ice, the
pellets were washed twice with the above buffers and resuspended in TM buffer.
For NaCl extraction of nuclei untreated with DNase I the same number of
cells was taken. The extraction procedure was carried out as described above,
but with 0.3 M and 0.5 M NaCl-supplemented TM buffers used for extraction.
For preparing a whole cell extract (input fraction) the cells were washed twice
with PBS, lysed in an IP buffer (50 mM Tris–HCl pH 8.0, 5 mM EDTA, 1%
SDS, protease inhibitors) and sonicated for 30 s (VirSonic 100, Virtis Corp.).
2.5. Immunoblotting
Equal aliquots of each fraction (corresponding to ∼15×106 cells for
extracted nuclei and∼5×106 cells for the input fraction) were separated by 10%
SDS-PAGE and blotted onto polyvinylidene difluoride membranes (Hybond-P,
Amersham Biosciences). The membranes were blocked over night in 5% dry
milk in PBS containing 0.1% Tween 20 (PBS-T) and incubated for 1 h with a
primary antibody diluted in PBS containing 0.02% Tween 20 and 1% bovine
serum albumin. After three washes with PBS-T, the membranes were incubated
for 1 h with secondary antibodies (horseradish peroxidase-conjugated anti-rabbit
IgG) in PBS containing 0.02% Tween 20 and 5% dry milk. The immunoblots
were visualized using an Amersham ECL kit. For data presentation, the films
were scanned and processed with Adobe Photoshop CS software.
2.6. Preparation of in situ nuclear matrices
To prepare in situ nuclear matrices, chicken RBCs and eRBCs were
resuspended in permeabilization buffer (10 mM PIPES, pH 7.8, 100 mM NaCl,
3 mMMgCl2, 0.5 mM phenylmethylsulfonyl fluoride, 0.1 mMCuSO4, 300 mM
sucrose and 0.5% (v/v) Triton X-100) at a final concentration of 2×106 cells/ml.
After 4 min incubation on ice, the cells were cytospinned onto silane-coated
microscope slides. The cells on the slides were then treated (4 min on ice) with
high-salt solution (2M NaCl, 10 mM PIPES, pH 6.8, 10 mM EDTA, 0.05 mM
spermine, 0.125 mM spermidine, 0.1% (w/v) digitonin) and after that
sequentially washed (1 min each washing) with 10×, 5×, 2× and 1× PBS and
then with 10, 30, 70 and 96% ethanol. After that the cells were washed twice with
TM buffer (50 mM Tris–HCl, pH 7.5, 3 mM MgCl2) and then treated with
RNase-free DNase I (100 μg/ml) for 30 min at 37 °C in TM buffer. The buffer
Fig. 1. Nuclear distribution of CTCF in proliferating and non-proliferating
chicken cells. Chicken HD3 cells (A, A′), CEFs (B, B′), eRBCs (C, C′) and
RBCs (D, D′) were immunostained with a polyclonal rabbit antibody against
CTCF revealed by Alexa 594-conjugated anti-rabbit IgG. Images were collected
using a Leica laser scanning confocal microscope. Only one representative
section is shown in each case. Pictures A′–D′ show DAPI staining of cells
demonstrated in A–D. Bar scale: 5 μm.
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NaCl and the cells were incubated in this buffer for 30 min on ice. The in situ
matrices obtained were washed twice with TM buffer, fixed with 4%
paraformaldehyde (PFA) for 30 min at room temperature and then used for
immunostaining.
3. Results
3.1. Nuclear distributions of CTCF are drastically different in
proliferating and non-proliferating chicken cells
In this study we used primary culture of chicken embryonic
fibroblasts (CEF) and three types of chicken erythroid cells: (i)
mature erythrocytes (RBC) with terminally repressed nuclei, (ii)
embryonic erythrocytes present in the blood of 9-day embryos
(eRBC) which actively transcribe globin genes along with a
number of housekeeping genes but do not proliferate and (iii)
cultured chicken erythroblasts transformed by AEV virus (HD3
cells). These cells actively proliferate but do not express globin
genes unless induced to differentiate. In the first set of
experiments we studied the distribution of CTCF in the above
described cells (Fig. 1). In proliferating HD3 cells CTCF was
present all over the nuclei being concentrated in numerous small
compartments (note the punctuate nuclear staining in Fig. 1A). A
similar distribution of CTCF was observed in non-erythroid
proliferating cells (chicken embryonic fibroblasts; Fig. 1B). In
these cells CTCFwas at least partially excluded from nucleoli. In
eRBC the nuclear distribution of CTCFwas drastically different.
CTCF was concentrated in a limited number of relatively large
compartments. A considerable portion of CTCF-containing
compartments was localized at the nuclear periphery. The rest
were distributed at random within the nuclear volume (Fig. 1C).
A similar distribution of CTCF was observed in mature
erythrocytes (Fig. 1D). To find out if CTCF is targeted to
nucleoli in eRBC, the cells were immunostained with antibodies
against CTCF and against fibrillarin (a nucleolar marker [21]).
The results of this experiment (Fig. 2A–A″ and B–D) did not
show any nucleolar targeting of CTCF. eRBC usually contain
two or more nucleoli. Frequently, some of CTCF-containing
compartments were localized close to the borders of nucleoli
(Fig. 2A–A″). However, the rest compartments were not
adjacent to nucleoli and CTCF staining was never detected
within nucleoli (Fig. 2A–A″). In many cells a CTCF-containing
compartment was found in the vicinity of only one of nucleoli or,
furthermore, all CTCF-containing compartments were far away
from nucleoli (Fig. 2B–D). Interestingly, a similar (peripheral
and perinucleolar) distribution of another transcription factor,
GATA-1, was observed in primary murine erythroblasts and
megakaryocytes [22]. On the other hand, there is a discrepancy
between these results and the results of Torrano et al. (2006) that
will be discussed below. It is of interest that large CTCF-
containing compartments were not formed in cultured HD3 cells
stimulated to terminal erythroid differentiation (data not shown).
This suggests that there might be a significant difference
between the processes of terminal differentiation of normal
erythrocytes and AEV-transformed cultured erythroblasts.
To find out if the CTCF-containing compartments colocalize
in RBC and eRBC with other known compartments, wevisualized Cajal bodies (using coillin [23] as a marker) and
splicing speckles (using SC35 [24] as a marker). Double
immunostaining experiments showed no significant colocaliza-
tion of CTCF-containing compartments with either Cajal bodies
or splicing speckles (Fig. 2E–G).
3.2. The nuclear distribution of CTCF in RBC and eRBC
differs from the distribution of the known CTCF partners Kaiso
and YB1
Kaiso, a POZ-zinc finger transcription factor, was identified
as a partner of CTCF in a yeast two-hybrid screen [25]. The
Fig. 2. CTCF-containing compartments are not a part of the major nuclear structures (nucleoli, Cajal bodies and splicing speckles). Chicken embryonic RBCs were
double-immunolabelled with a mouse monoclonal antibody against fibrillarin (A) and a rabbit polyclonal antibody against CTCF (A′). Superimpositions of A and A′
with a phase contrast image is shown as A″. (B–D) Several merged images (made in the same fashion as shown in A″) showing the peripheral and perinucleolar
localization of CTCF in eRBCs. (E) eRBC double-immunolabeled with a mouse monoclonal antibody against coilin (green staining) and a rabbit polyclonal antibody
against CTCF (red staining). (F and G) eRBC and RBC double-immunolabeled with a mouse monoclonal antibody against SC35 (green staining) and a rabbit
polyclonal antibody against CTCF (red staining). The images were taken using a Leica laser scanning confocal microscope equipped with a 63× objective. Bar scale:
5 μm.
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also identified as one of CTCF partners. Furthermore, the
interaction of these proteins was found to occur in living cells
and be functionally significant [26]. We were interested to find
out if in chicken embryonic fibroblasts and in different types of
chicken erythroid cells the above-mentioned CTCF partners
were present in nuclear compartments containing CTCF. Thus
double staining of CEF, eRBC and RBC nuclei with antibodies
against CTCF and against Kaiso or YB-1 was done. In CEF
both YB-1 and Kaiso were distributed almost at random over
the whole nucleus while CTCF showed a punctuate distribution
(Fig. 3A–A″ and D–D″). Although in both cases the small
CTCF-containing compartments overlapped the areas contain-
ing either Kaiso or YB-1, this kind of overlapping cannot be
interpreted as an indication of true colocalization of CTCF with
Kaiso or YB-1. In eRBC and RBC Kaiso and YB-1 were
distributed in a more specific way (Fig. 3B–B″, C–C″, E–E″
and F–F″). As expected, in these cells CTCF was concentrated
in large compartments described in the previous section. No
significant overlapping of CTCF-containing compartments with
the areas containing Kaiso was observed. As for YB1, in RBC apartial colocalization of this factor and the CTCF-containing
compartments were observed (Fig. 3F–F″). It was interesting
that the pattern of nuclear distribution of Kaiso resembled that
of CTCF. Namely, punctuate nuclear staining was observed in
primary fibroblasts and large speckles in eRBC and RBC.
3.3. CTCF does not degrade via the proteasomal system in
eRBC and in mature erythrocytes
We hypothesized that the concentration of CTCF and
possibly of other transcription factors in large nuclear speckles
must be necessary for their targeted degradation in the course of
inactivation of erythrocyte nuclei. To test this hypothesis, we
examined the presence of proteasomes in CTCF-containing
compartments. Antibodies against proteasome core proteins
p23 (HC7-I) and p27 (Pros-27 or iota) [27,28] were used for
double immunostaining of proteasomes and CTCF. In general,
no significant colocalization of proteasomes and CTCF-
containing compartments was detected in eRBC and in mature
erythrocytes (Fig. S1). In eRBC partial overlapping of CTCF-
containing compartments with p23-containing proteasomes was
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Fig. 4. CTCF-containing compartments are excluded from chromatin in chicken mature erythrocytes (RBCs). Chicken eRBC (A–A″) and RBC (B–B″) were
immunostained with rabbit polyclonal antibodies against CTCF (A–C) along with DAPI staining of chromosomal DNA (A′–C′). An enlarged part of the CTCF-
stained erythrocyte nucleus is shown (C–C″). Superimposition of corresponding images is shown as A″–C″. The images were collected using a Leica DRMB
fluorescence microscope equipped with a 100× objective. Bar scale: 5 μm.
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significance of this overlapping observed only in some cells
is, however, questionable. Indeed, most of the p23-type
proteasomes present in the nucleus were concentrated in the
peripheral layer and their occasional overlapping with the
CTCF-containing compartments is likely to be an incidental
event rather than a true colocalization.
3.4. In mature erythrocytes CTCF, Kaiso, YB-1, CREB and
RNA polymerase II are excluded from chromatin
Examination of mature chicken erythrocyte nuclei double
stained with DAPI (DNA staining) and with antibody against
CTCF clearly demonstrated the localization of CTCF-contain-
ing compartments in DAPI-negative areas, i.e. within the
interchromatin domain (Fig. 4B–B″ and C–C″). Thus, although
being present in nuclei of mature erythrocytes, CTCF can hardly
fulfill its normal function as it is stored outside the chromatin
domain.Wewere curious to find out if other transcription factors
were excluded from chromatin in a similar fashion. Therefore,Fig. 3. CTCF does not participate in the protein–protein interactions with the known
eRBCs (B–B″, E–E″) and RBCs (C–C″, F–F″) were double-immunolabelled with
monoclonal anti-Kaiso or with a rat polyclonal anti-YB-1 antibodies (A–C and D–F,
taken using a Leica DRMB fluorescence microscope equipped with a 100× objectivthe localization of Kaiso, YB-1 and CREB in respect to the
DAPI-positive domain was analyzed. The results obtained (Fig.
5A–A‴ and B–B‴ and Fig. S2) were basically the same as those
obtained for CTCF. All three transcription factors were
concentrated in large spots (compartments) which were present
only in DAPI-negative areas. Furthermore, a similar exclusion
pattern was observed for RNA polymerase II (Fig. S2). Thus,
exclusion from the chromatin domain of RNA polymerase II and
normal components of transcription regulation is likely to be a
general phenomenon in the course of inactivation of erythrocyte
nuclei.
3.5. In eRBC but not in mature erythrocytes a major part of
CTCF is associated with DNA
In the last set of experiments we analyzed the possibility of
extracting CTCF from nuclei of eRBC and mature erythrocytes.
Both types of nuclei were extracted with 0.3 M, 0.5 M or 2 M
NaCl and the portion of CTCF remained in the nuclear pellet
was compared with that in non-extracted nuclei. In somepartners Kaiso and YB-1 in eRBCs and RBCs. Chicken CEFs (A–A″, D–D″),
a rabbit polyclonal antibody against CTCF (A′–F′) and either with a mouse
respectively). The superimposed images are shown as A″–F″. The images were
e. Only one representative section is shown in each case. Bar scale: 5 μm.
Fig. 5. Kaiso and YB-1 are excluded from chromatin in RBCs but did not overlap with CTCF-containing compartments. Chicken RBC were double-immunolabeled
with a rabbit polyclonal antibody against CTCF (A′–B′) and with a mouse monoclonal anti-Kaiso (A) or with a rat polyclonal anti-YB-1 (B) antibodies along with
DAPI staining of chromosomal DNA (A″–B″). Superimposition of corresponding images is shown as A‴–B‴. The images were collected using a Leica DRMB
fluorescence microscope equipped with a 100× objective. Bar scale: 5 μm.
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extraction. Aliquots of non-extracted and extracted nuclei were
separated by SDS-gel electrophoresis and, after Western
blotting, CTCF was visualized by immunostaining. The results
are presented in Fig. 6. In mature erythrocytes a large portion of
CTCF (∼ 30%) remained associated with nuclear remnants
(nuclear matrices) regardless of DNase I treatment and the
concentration of NaCl (0.3 M, 0.5 M or 2 M) used for extrac-
tion (Fig. 6A and B). In contrast, virtually all CTCF was
extracted from eRBC nuclei treated with DNAse I (Fig. 6B).
This result suggests that in active nuclei of eRBC a significant
portion of CTCF is bound to DNAwhile in mature erythrocytes
it is bound to the nuclear matrix. This conclusion was con-
firmed by immunostaining of the so-called in situ nuclear
matrices [29] with CTCF-specific antibodies (Fig. 6C). In these
experiments the nuclear matrices obtained from eRBC and
RBC treated with DNase I and extracted with 2 M NaCl were
compared. Large CTCF-containing compartments were clearly
seen in the nuclear matrices obtained from RBC, while no
CTCF was detected in the nuclear matrices obtained from
eRBC (Fig. 6C).
Interestingly, in the nuclear matrices prepared from RBC
CTCF was represented by two bands with apparent molecular
weights of 155 and 90 kDa (Fig. 6A, B). The band with an
apparent molecular weight of 90 kDa most likely represents the
truncated form of CTCF resulting from a site-specific cleavage
by endogenous proteases in the course of incubation of per-
meabilised cells with DNase I at 37 °C [14,30]. It is important
that in all cases lamin B, a characteristic component of the
nuclear matrix [31], fully remained in thematrices prepared from
eRBC and RBC by a conventional protocol including DNase I
treatment and 2M NaCl extraction (Fig. 6D). Thus, the different
representation of CTCF in nuclear matrices obtained from eRBCand RBC cannot be explained by degradation of nuclear matrices
prepared from eRBC.
4. Discussion
CTCF is a versatile transcription factor that fulfills different
functions in the regulation of gene activity [16]. Although
recent studies have been focused mainly on the necessity of
CTCF for the function of mammalian insulators [32], initially
this protein was identified as a transcription factor regulating c-
myc gene activity [14]. It becomes increasingly evident that
targeting of transcription factors to particular nuclear compart-
ments plays an important role in the control of genome activity
(including both replication and transcription). According to
recently published data, CTCF might play an important role in
triggering terminal differentiation of erythroid cells [33]. While
in mammals terminally differentiated erythrocytes do not
contain nuclei, mature avian erythrocytes do not lose nuclei.
Nevertheless terminal differentiation of avian erythroid cells
involves significant changes in the nuclear organization
associated with complete inactivation of the genome. Taking
into account a possible role of CTCF in erythroid cell dif-
ferentiation [33] it was interesting to find out if the nuclear
distribution of CTCF in avian erythrocytes and erythroblasts
shows some characteristic features. Up to now the nuclear
distribution of CTCF has been studied only in proliferating
cultured mammalian cells [34] or cultured mammalian cells
stimulated to differentiation [33]. It was reported that CTCF
might play an important role in the arrest of cell proliferation by
blocking nucleolar gene transcription and possibly by affecting
other unknown nucleolar functions. This assumption was based
on the observation that CTCF is targeted to nucleoli in the
course of induced differentiation of cultured erythroid cells (line
Fig. 6. CTCF is associated with DNA in nuclei of eRBC but not of mature
erythrocytes. Chicken RBC (A) and eRBC (B) were subjected to NaCl
extraction combined (lanes 2 and 3 in pictures A and B) or not (lanes 4 and 5)
with DNase I treatment. Equal aliquots of each fraction (corresponding to
∼15×106 cells for extracted nuclei and ∼5×106 cells for the input fraction)
were separated by 10% SDS-PAGE and analyzed via immunoblotting using
CTCF-specific antibodies. Positions of protein markers are shown as rectangles
on the left. Whole cell extract was used as input fraction (I) in all immuno-
blotting experiments. (C) In situ nuclear matrices obtained from chicken eRBCs
and RBCs were double-immunolabeled with antibodies against CTCF and lamin
B. The images were collected using a Leica DRMB fluorescence microscope
equipped with a 100× objective. Only one representative section is shown in
each case. Bar scale: 5 μm. (D) Chicken eRBC and RBC were subjected to NaCl
extraction combined with DNase I treatment. Equal aliquots of each fraction
(corresponding to ∼15×106 cells for extracted nuclei and ∼5×106 cells for the
input fraction) were separated by 10% SDS-PAGE and analyzed via
immunoblotting using lamin B-specific antibodies. The position of lamin B is
indicated by arrows on the left of picture (upper—lamin B, under—truncated
form of lamin B). Whole cell extract was used as input fraction (I) in all
immunoblotting experiments.
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[17]. We did not manage to demonstrate the same in our
experimental model (normal embryonic and mature chicken
erythrocytes). In contrast, we found that in both embryonic and
mature chicken eryhrocytes CTCF was concentrated in large
nuclear compartments which only occasionally colocalized with
nucleoli in embryonic erythrocytes and were excluded from
chromatin in mature erythrocytes. Interestingly, several other
transcription factors and RNA polymerase II were distributed in
a similar fashion. The disagreement between our observationsand the data published by Torrano et al. (2006) may reflect the
basic differences between cancer cells studied by Torrano et al.
(2006) and normal cells studied in the present work. This
supposition is indirectly supported by the fact that we did not
observe large CTCF-containing compartments in cultured AEV-
transformed chicken pre-erythroblasts induced to terminal
erythroid differentiation. Another possibility is that different
mechanisms are involved in terminal differentiation of erythroid
cells (which includes the arrest of both proliferation and
transcription in mature erythrocytes) and in differentiation of
other cells that remain transcriptionally active despite the stop
of proliferation.
Large nuclear compartments containing CTCF were not
observed previously in normal cells although they were seen in
cultured cells where CTCF was overexpressed from a trans-
fected plasmid construct [33]. In chicken eRBC large nuclear
compartments containing CTCF (as well as similar compart-
ments containing RNA polymerase II and different transcription
factors) partially overlap with the chromatin domain while in
mature erythrocytes they are completely excluded from this
domain. Interestingly, the nuclear compartments containing
CTCF and other transcription factors studied in the present work
(CREB, Kaiso) do not overlap with each other and do not
colocalize with the major nuclear compartments (nucleoli, Cajal
bodies, splicing speckles).
In agreement with the above-mentioned observations
demonstrating that in eRBC CTCF, already concentrated within
large compartments, is not excluded from the chromatin domain,
we have found that it still interacts with DNA. This follows from
the fact that preservation of DNA is essential for keeping CTCF
in eRBC nuclei upon middle-salt extraction. The conclusion that
in eRBC CTCF interacts with the target DNA sequences is also
supported by the results of our previous study [35]. In this study
it was demonstrated that in eRBC CTCF interacted with an
enhancer-blocking element in the upstream area of the chicken
alpha-globin gene domain. In mature erythrocytes a large
portion of CTCF is associated with the nuclear matrix as it
cannot be extracted from DNase I treated nuclei even by 2 M
NaCl solution. Furthermore, removal of chromatin from mature
erythrocytes did not affect the integrity of CTCF-containing
compartments. They still could be observed in nuclear matrices.
In contrast, CTCF was not present in nuclear matrices obtained
from eRBC. In the previous study of Yusufzai and Felsenfeld
CTCF was found to remain in the nuclear matrix fraction after
DNase I treatment and 2 M NaCl extraction of isolated nuclei of
cultured human erythroid cells (line K562) [36]. The apparent
contradiction between these results and our results obtained in
experiments with eRBCmost probably reflects some differences
in the procedure used to prepare nuclear matrices. Thus, the
above-cited authors used Ca2+ ions in the course of nuclear
matrix preparation while we used Mg2+ ions. It was reported
previously that incubation of nuclei at 37 °C with Ca2+ ions but
not with Mg2+ ions additionally stabilized the nuclear matrix
[37]. Our own experience (see [38]) and the experience of other
authors indicates that the protein composition of nuclear
matrices drastically depends on the method used for their
preparation [39–43]. Taking into account the fact that the
932 O.L. Kantidze et al. / Biochimica et Biophysica Acta 1773 (2007) 924–933nuclear matrix is an operationally defined structure, we thought
that it would be more informative to compare nuclear matrices
prepared from different cells by using the same isolation
procedure. That is why in the present work nuclear matrices were
isolated from eRBC and from mature erythrocytes. We found it
extremely interesting that in mature erythrocytes association of
CTCF with the nuclear matrix correlates with its exclusion from
the chromatin domain. It is reasonable to suggest that this
exclusion reinforced by fixation of CTCF (and possibly other
components of the transcriptional machinery) at the nuclear
matrix in the interchromatin domain (perhaps within the nuclear
matrix channels [44]) is an important step of the terminal
inactivation of avian erythrocyte nuclei.
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